Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2438]

HKBU and CUHK launch spermine risk score for prostate cancer diagnosis

HKBU and CUHK launch spermine risk score for prostate cancer diagnosis

ASCO GU 2021: Immunotherapy nivolumab doubles disease-free survival in a type of high-risk urothelial carcinoma

ASCO GU 2021: Immunotherapy nivolumab doubles disease-free survival in a type of high-risk urothelial carcinoma

Using MRI for prostate cancer diagnosis equals or beats current standard

Using MRI for prostate cancer diagnosis equals or beats current standard

European Cancer Patient Coalition comments on EU's cancer beating plan

European Cancer Patient Coalition comments on EU's cancer beating plan

Ultrasound technique treats prostate cancer with minimal side effects

Ultrasound technique treats prostate cancer with minimal side effects

Shorter radiotherapy course reduces risk of bladder cancer returning

Shorter radiotherapy course reduces risk of bladder cancer returning

European commission approves avelumab for first-line maintenance treatment of locally advanced or metastatic urothelial carcinoma

European commission approves avelumab for first-line maintenance treatment of locally advanced or metastatic...

FDA approves nivolumab plus cabozantinib for advanced renal cell carcinoma

FDA approves nivolumab plus cabozantinib for advanced renal cell carcinoma

Dramatic changes to radiotherapy treatments in England due to COVID-19

Dramatic changes to radiotherapy treatments in England due to COVID-19

Bladder cancer - When to use chemotherapy

Bladder cancer - When to use chemotherapy

More from ecancer